<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In some patients with <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, it is difficult to determine whether the condition is caused by underproduction of platelets (<z:mp ids='MP_0008255'>reduced numbers of megakaryocytes</z:mp>) or an increase in the rate of their destruction (<z:mpath ids='MPATH_458'>normal</z:mpath> or <z:mp ids='MP_0008254'>increased numbers of megakaryocytes</z:mp>) </plain></SENT>
<SENT sid="1" pm="."><plain>A non-invasive test to help distinguish between these two categories of <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> would be useful </plain></SENT>
<SENT sid="2" pm="."><plain>We related the plasma concentration of glycocalicin, a fragment of the platelet-membrane <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> Ib, to the mechanism of <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> by evaluating bone marrow megakaryocyte content and measuring platelet life span </plain></SENT>
<SENT sid="3" pm="."><plain>Plasma glycocalicin was measured with a monoclonal antibody to the glycocalicin component of platelet <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> Ib </plain></SENT>
<SENT sid="4" pm="."><plain>The mean (+/- SD) plasma concentration of glycocalicin in 34 healthy controls was 87 +/- 20 percent of the level in pooled <z:mpath ids='MPATH_458'>normal</z:mpath> plasma (range, 52 to 127 percent) </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of eight patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> or <z:hpo ids='HP_0004859'>amegakaryocytic thrombocytopenia</z:hpo> confirmed by examining bone marrow (in <z:hpo ids='HP_0000001'>all</z:hpo> patients) and by determining the life span of autologous platelets (in six patients) had glycocalicin levels significantly below the <z:mpath ids='MPATH_458'>normal</z:mpath> range (5 to 27 percent) </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, each of 25 patients with <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> thought to be caused by a reduction in platelet life span, whose bone marrow contained <z:mpath ids='MPATH_458'>normal</z:mpath> or <z:mp ids='MP_0008254'>increased numbers of megakaryocytes</z:mp>, had glycocalicin levels that fell within or above the <z:mpath ids='MPATH_458'>normal</z:mpath> range (48 to 261 percent) </plain></SENT>
<SENT sid="7" pm="."><plain>There was no overlap of values between the two patient populations </plain></SENT>
<SENT sid="8" pm="."><plain>These studies indicate that the measurement of plasma glycocalicin may be a useful adjunct in classifying <z:e sem="disease" ids="C0040034" disease_type="Disease or Syndrome" abbrv="">thrombocytopenic disorders</z:e> </plain></SENT>
</text></document>